CRON Cronos Group Inc. Common Share
$3.38▲ +2.11%
Healthcare
Other
After hours
$3.39▲ +0.21%
Oct 27, 5:39 PM ET
Volume 736.9K
Avg Volume (10D) 859.7K
Key Metrics & Fundamentals
Market Cap
$1.25B
P/E Ratio
17.8
Div Yield
0.00%
52W Range
2.28 - 3.61
% vs 50 MA
2.54%
% vs 200 MA
18.86%
RSI-14
57.4
MACD Histogram
+0.0100
Beta (1Y vs SPY)
0.60
Free Cash Flow
$22.23M
Gross Rev
$53.01M
Gross Profit
$28.45M
EBITDA
-$8.32M
COGS
$24.56M
Operating Exp
$20.85M
Operating Income
$7.60M
EBIT
$7.60M
Pretax Income
$35.71M
Net Income
$32.09M
EPS (Diluted)
0.09
Price & Volume History
Loading chart…
Recent News

3 Canadian Penny Stocks With P E Under 18
Simply Wall St. · Oct 27, 2026 5:09 PM ET

3 Canadian Penny Stocks With Net Margins Over 39%
Simply Wall St. · Oct 26, 2026 9:09 AM ET

Are Medical Stocks Lagging Cronos Group (CRON) This Year?
Zacks · Oct 26, 2026 8:50 AM ET

3 Canadian Penny Stocks With Fair Value Gaps Over 70%
Simply Wall St. · Oct 25, 2026 8:24 PM ET

3 Canadian Penny Stocks With Up To 67% Return On Equity
Simply Wall St. · Oct 25, 2026 4:08 AM ET

3 Canadian Penny Stocks With Net Margins Over 39%
Simply Wall St. · Oct 23, 2026 12:11 PM ET

Cronos (CRON) Upgraded to Strong Buy: Here's What You Should Know
Zacks · Oct 23, 2026 11:00 AM ET

3 Canadian Biotech Stocks With Up To 39% Net Margins
Simply Wall St. · Oct 22, 2026 12:14 PM ET

3 Canadian Penny Stocks To Own In October 2026
Simply Wall St. · Oct 20, 2026 10:12 AM ET
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Market Exclusive · Oct 19, 2026 9:22 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See CRON's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.